Latest Posts

Have Your Say on Federal Food Regulatory Change: Consultation Open On Draft Safe Food For Canadians Regulations

In January 2017, draft regulations under the Safe Food For Canadians Act (which was passed in November 2012) were published.  The draft Regulations can be found here.

Read Full Article
Health Canada Announces Random Testing of Medical Cannabis for Prohibited Pest Control Product Use

In an announcement earlier today, Health Canada advised that it will be conducting random testing of medical cannabis products produced by licensed producers. 

Read Full Article
Canada’s Excessive Pricing Regulations Survive Another Constitutional Challenge

The Patented Medicine Prices Review Board (the “PMPRB”) commenced a proceeding against Alexion Pharmaceuticals Inc. (“Alexion”) in respect of Alexion’s drug, SOLIRIS (eculizumab), which is used to treat rare and devastating blood and genetic conditions. The PMPRB claimed and successfully argued that Alexion was selling Soliris at an excessive price, under sections 82 and 85 of the Patent Act.

Read Full Article
To Engage or Not to Engage: Guidance on Motions to Strike a Within Application

The Federal Court has reaffirmed and clarified how a pharmaceutical brand company should respond to a generic company’s motion to strike an application for abuse of process under s. 6(5)(b) of the Patented Medicines (Notice of Compliance) Regulations.

Read Full Article
Key Takeaways from the 2017 Cantech Investment Conference

On January 18, 2017, investors, analysts, and entrepreneurs converged on the Metro Toronto Convention Centre for the 2017 Cantech Investment Conference. Exhibitors at the conference spanned a number of industries from cybersecurity to specialty finance to cannabis.

Read Full Article
The Academies Release Major Report on Cannabis and Cannabis-derived Products

The National Academies of Sciences, Engineering, and Medicine has released a major US government-funded report entitled "The Health Effects of Cannabis and Cannabinoids: The Current States of Evidence and Recommendations for Research" (the "Report") outlining benefits and harms associated with cannabis on a range of public health and safety issues. Cannabis scientific and medical research has historically been impeded because of its illegality, stigma, and related challenges, so the report represents a major positive step towards providing guidance and evidence-based research for physicians, researchers, and patients alike.

Read Full Article
Cameron Mingay Discusses Divesting for Growth

In the pharmaceutical and biotechnology industry, strategic acquisitions and consolidation are often pointed to as the prevailing trends. However, divestment of non-core business units has become an important tool to drive strategic growth across all industries, including in the life sciences sector.

Read Full Article
Time to Change Food Labels

On December 14, the Honourable Jane Philpott, Minister of Health, announced amendments to the Food and Drug Regulations regarding the nutrition facts table and list of ingredients on packaged foods.  As discussed in our October 2016 blog post, the amendments are part of the Government of Canada’s Vision for a Healthy Canada initiative.

Read Full Article
December 2016 Deal Round-Up

The following is a summary of major deals in the life science space that closed or were announced in December 2016. 

Read Full Article
Health Canada Releases New Biosimilar Biologic Drugs Guidance Document

Health Canada has recently released the revised Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs (the “Guidance Document”), replacing the March 2010 Guidance for Sponsors: Information and Submission Requirements for Subsequent Entry Biologics. The Guidance Document is meant to provide assistance to industry and health care professionals on how to comply with governing statutes and regulations, but does not have the force of law. The Guidance Document is one of the primary resources provided by Health Canada regarding approval of biosimilars.

Read Full Article
One Step Closer to Legalization of Marijuana in Canada: Release of Task Force Recommendations for Regulation of Cannabis

The Task Force on Cannabis Legalization and Regulation publicly released its report today outlining its recommendations on the Legalization and Regulation of Cannabis in Canada. 

Read Full Article
Deciphering the Term Sheet: Valuation

This article is the first in a series of articles that will delve into the most important terms in investment Term Sheets for early-stage companies.

Read Full Article
November 2016 Deal Round-Up

The following is a summary of major deals in the life science space that closed or were announced as closed in November 2016. 

Read Full Article
Tips for First-Time Investment Fundraisers

The first time a venture seeks external fundraising, often from an angel investor or venture capital firm, is a major milestone. The following suggests some tactical tools for reaching out to, and getting the attention and interest of, these investors:

Read Full Article
Canada Introduces Vaping Legislation

On November 22nd, new legislation was introduced (Bill S-5) that proposes significant changes to the Tobacco Act to institute regulation of vaping products and implement other changes to the regulation of tobacco products.

Read Full Article
October 2016 Deal Round-Up

A monthly round-up of a selection of major Canadian deals in the life sciences and healthcare sector.

Read Full Article
New US$500 Million Global Life Sciences Venture Fund Launched

Quark Venture Inc., a Canadian based venture firm, and GF Securities Company Limited, a China based investment bank, have recently launched a US$500 million life sciences venture capital fund. The fund will be based out of Vancouver, and is expected to focus on building a diversified portfolio of innovative biotechnology, pharmaceutical, and life sciences companies. It is now the largest life science fund in Canada and has already committed US$100 million into various life sciences companies.

Read Full Article
Food For Thought: Changes Impacting the Content, Labelling and Marketing of Food Products in Canada Announced

Canada’s Minister of Health has announced the launch of a new Healthy Eating Strategy that will impact manufacturers, distributors and retailers of food products in Canada. This initiative proposes to implement changes to the way that foods are produced, labelled and marketed in an effort to address obesity, diabetes, heart disease and other chronic health conditions.

Read Full Article
Developing Toronto's Life Science and Healthcare Innovation Economy

The core theme of the 2016 World Economic Forum in Davos, Switzerland was the arrival of the Fourth Industrial Revolution, with its velocity, scope and disruptive impact on almost every industry of every country.1  Much of the change is attributable to the creation and duplication of the digital universe of data, believed to be expanding by 40% per year.2  One of the sectors which is expected to be radically altered, and benefit significantly, is life sciences, and particularly, healthcare.

Read Full Article
The Capital Landscape for Early-Stage Life Science Ventures

As an early-stage start-up, regardless of industry, understanding the players in the investment landscape is important. Over the past several years, the types of investors interested in early-stage life science ventures has diversified, with investors that would normally invest at later stages now often looking to fund companies at earlier stages of commercialization.1  The following is a cross-section of the key players.

Read Full Article
Prev 1 2 3 Next